HB 2127, the Texas Regulatory Consistency Act, preempts a broad swath of local regulatory powers by stipulating that “unless expressly authorized by another statute, a [city] may not adopt ...
Additional information on the Phase 1a/b clinical trial can be accessed at www.clinicaltrials.gov (NCT05131022). About NX-2127: NX-2127 is an investigational, orally bioavailable degrader of BTK and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback